60 related articles for article (PubMed ID: 20937240)
21. Protein tyrosine phosphatase 1B (PTP1B) is involved in the defective erythropoietic function of carbamylated erythropoietin.
Chamorro ME; Maltaneri RE; Vittori DC; Nesse AB
Int J Biochem Cell Biol; 2015 Apr; 61():63-71. PubMed ID: 25668475
[No Abstract] [Full Text] [Related]
22. Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase.
Li S; Depetris RS; Barford D; Chernoff J; Hubbard SR
Structure; 2005 Nov; 13(11):1643-51. PubMed ID: 16271887
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma 1 in a human erythropoietin-dependent cell line.
Ren HY; Komatsu N; Shimizu R; Okada K; Miura Y
J Biol Chem; 1994 Jul; 269(30):19633-8. PubMed ID: 8034732
[TBL] [Abstract][Full Text] [Related]
24. Role of protein tyrosine phosphatase 1B (PTP1B) in the increased sensitivity of endothelial cells to a promigratory effect of erythropoietin in an inflammatory environment.
Chamorro ME; Maltaneri R; Schiappacasse A; Nesse A; Vittori D
Biol Chem; 2020 Sep; 401(10):1167-1180. PubMed ID: 32386183
[TBL] [Abstract][Full Text] [Related]
25. TRPC3 is the erythropoietin-regulated calcium channel in human erythroid cells.
Tong Q; Hirschler-Laszkiewicz I; Zhang W; Conrad K; Neagley DW; Barber DL; Cheung JY; Miller BA
J Biol Chem; 2008 Apr; 283(16):10385-95. PubMed ID: 18276585
[TBL] [Abstract][Full Text] [Related]
26. Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway.
Hamel-Côté G; Gendron D; Rola-Pleszczynski M; Stankova J
PLoS One; 2017; 12(7):e0180336. PubMed ID: 28686728
[TBL] [Abstract][Full Text] [Related]
27. DOT1L Methyltransferase Regulates Calcium Influx in Erythroid Progenitor Cells in Response to Erythropoietin.
Feng Y; Borosha S; Ratri A; Lee EB; Wang H; Fields TA; Kinsey WH; Vivian JL; Rumi MAK; Fields PE
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563527
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin increases expression and function of transient receptor potential canonical 5 channels.
Liu Y; Xu Y; Thilo F; Friis UG; Jensen BL; Scholze A; Zheng J; Tepel M
Hypertension; 2011 Aug; 58(2):317-24. PubMed ID: 21690481
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin rapidly induces tyrosine phosphorylation in the human erythropoietin-dependent cell line, UT-7.
Komatsu N; Adamson JW; Yamamoto K; Altschuler D; Torti M; Marzocchini R; Lapetina EG
Blood; 1992 Jul; 80(1):53-9. PubMed ID: 1377053
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models.
Katz O; Stuible M; Golishevski N; Lifshitz L; Tremblay ML; Gassmann M; Mittelman M; Neumann D
J Endocrinol; 2010 Apr; 205(1):87-95. PubMed ID: 20061512
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin modulates calcium influx through TRPC2.
Chu X; Cheung JY; Barber DL; Birnbaumer L; Rothblum LI; Conrad K; Abrasonis V; Chan YM; Stahl R; Carey DJ; Miller BA
J Biol Chem; 2002 Sep; 277(37):34375-82. PubMed ID: 12167663
[TBL] [Abstract][Full Text] [Related]
32. Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets.
Kuchay SM; Kim N; Grunz EA; Fay WP; Chishti AH
Mol Cell Biol; 2007 Sep; 27(17):6038-52. PubMed ID: 17576811
[TBL] [Abstract][Full Text] [Related]
33. Does Erythropoietin Regulate TRPC Channels in Red Blood Cells?
Danielczok J; Hertz L; Ruppenthal S; Kaiser E; Petkova-Kirova P; Bogdanova A; Krause E; Lipp P; Freichel M; Kaestner L; Birnbaumer L
Cell Physiol Biochem; 2017; 41(3):1219-1228. PubMed ID: 28268218
[TBL] [Abstract][Full Text] [Related]
34. Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening.
Noomuna P; Hausman JM; Sansoya R; Kalfa T; Risinger M; Low PS
FASEB J; 2022 Jun; 36(6):e22360. PubMed ID: 35593742
[TBL] [Abstract][Full Text] [Related]
35. Regulation of PTP1B activation through disruption of redox-complex formation.
Londhe AD; Bergeron A; Curley SM; Zhang F; Rivera KD; Kannan A; Coulis G; Rizvi SHM; Kim SJ; Pappin DJ; Tonks NK; Linhardt RJ; Boivin B
Nat Chem Biol; 2020 Feb; 16(2):122-125. PubMed ID: 31873221
[TBL] [Abstract][Full Text] [Related]
36. Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor.
Iwamoto N; Sumi D; Ishii T; Uchida K; Cho AK; Froines JR; Kumagai Y
J Biol Chem; 2007 Nov; 282(46):33396-33404. PubMed ID: 17878162
[TBL] [Abstract][Full Text] [Related]
37. Minimally disruptive optical control of protein tyrosine phosphatase 1B.
Hongdusit A; Zwart PH; Sankaran B; Fox JM
Nat Commun; 2020 Feb; 11(1):788. PubMed ID: 32034150
[TBL] [Abstract][Full Text] [Related]
38. Immobilization of erythropoietin to culture erythropoietin-dependent human leukemia cell line.
Ito Y; Hasuda H; Yamauchi T; Komatsu N; Ikebuchi K
Biomaterials; 2004 May; 25(12):2293-8. PubMed ID: 14741594
[TBL] [Abstract][Full Text] [Related]
39. Analysis of PTP1B sumoylation.
Saha S; Chernoff J
Methods; 2014 Jan; 65(2):201-6. PubMed ID: 24076082
[TBL] [Abstract][Full Text] [Related]
40. Design and application of anthracene derivative with aggregation-induced emission charateristics for visualization and monitoring of erythropoietin unfolding.
Sun B; Yang X; Ma L; Niu C; Wang F; Na N; Wen J; Ouyang J
Langmuir; 2013 Feb; 29(6):1956-62. PubMed ID: 23323829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
